---
title: "Xeltis poised to commercialise aXess vascular access conduit following pivotal trial results"
date: "2025-09-25T12:04:48.000Z"
publishedDate: "25 septembre 2025"
summary: "Xeltis has announced clinical data from the aXess EU pivotal trial the prospective study investigating the patency, safety, and performance of its restorative vascular access conduit— aXess—in adult patients with end-stage renal disease requiring vascular access to start or maintain haemodialysis therapy. The results from the trial, which was conducted in 18 centres across Europe, [&#8230;] The post Xeltis poised to commercialise aXess vascular access conduit following pivotal trial results appeared first on Vascular News ."
importance: ""
sourceUrl: "https://vascularnews.com/xeltis-poised-to-commercialise-axess-vascular-access-conduit-following-pivotal-trial-results/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2025-09-25-xeltis-poised-to-commercialise-axess-vascular-access-conduit-following-pivotal-trial-results"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2025/01/new-xeltis-axess-pic-featured.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/xeltis-poised-to-commercialise-axess-vascular-access-conduit-following-pivotal-trial-results/"
---

![Xeltis poised to commercialise aXess vascular access conduit following pivotal trial results](https://vascularnews.com/wp-content/uploads/sites/7/2025/01/new-xeltis-axess-pic-featured.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/xeltis-poised-to-commercialise-axess-vascular-access-conduit-following-pivotal-trial-results/*

## L’essentiel

Xeltis has announced clinical data from the aXess EU pivotal trial the prospective study investigating the patency, safety, and performance of its restorative vascular access conduit— aXess—in adult patients with end-stage renal disease requiring vascular access to start or maintain haemodialysis therapy. The results from the trial, which was conducted in 18 centres across Europe, [&#8230;] The post Xeltis poised to commercialise aXess vascular access conduit following pivotal trial results appeared first on Vascular News .

## Lien source

https://vascularnews.com/xeltis-poised-to-commercialise-axess-vascular-access-conduit-following-pivotal-trial-results/
